Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancerRenske A de Jong, Hans W Nijman, H Marike Boezen, et al.
Oncoimmunology|September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancerFenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Clinical Chemistry|March 26, 2003
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomasWim G Meijer, Sjef C V M Copray, Harry Hollema, et al.
Breast Cancer Research and Treatment|December 8, 2007
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancerWilhelmina E Hoogendoorn, Harry Hollema, Hester H van Boven, et al.
The Journal of Biological Chemistry|January 9, 2007
Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformationIván Plaza-Menacho, Tineke van der Sluis, Harry Hollema, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Gene promoter methylation patterns throughout the process of cervical carcinogenesisNan Yang, Esther R Nijhuis, Haukeline H Volders, et al.
Genes, Chromosomes & Cancer|January 10, 2009
PMS2 involvement in patients suspected of Lynch syndromeRenée C Niessen, Jan H Kleibeuker, Helga Westers, et al.
Clinical & Developmental Immunology|October 2, 2010
Potential target antigens for a universal vaccine in epithelial ovarian cancerRenee Vermeij, Toos Daemen, Geertruida H de Bock, et al.
Gynecologic Oncology|November 16, 2017
Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic reviewNienke C Te Grootenhuis, Anne-Floor W Pouwer, Geertruida H de Bock, et al.
Gynecologic Oncology|December 5, 2009
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancerEvelien W Duiker, Ate G J van der Zee, Pauline de Graeff, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancerRenske A de Jong, Hans W Nijman, H Marike Boezen, et al.
Oncoimmunology|September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancerFenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Clinical Chemistry|March 26, 2003
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomasWim G Meijer, Sjef C V M Copray, Harry Hollema, et al.
Breast Cancer Research and Treatment|December 8, 2007
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancerWilhelmina E Hoogendoorn, Harry Hollema, Hester H van Boven, et al.
The Journal of Biological Chemistry|January 9, 2007
Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformationIván Plaza-Menacho, Tineke van der Sluis, Harry Hollema, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Gene promoter methylation patterns throughout the process of cervical carcinogenesisNan Yang, Esther R Nijhuis, Haukeline H Volders, et al.
Genes, Chromosomes & Cancer|January 10, 2009
PMS2 involvement in patients suspected of Lynch syndromeRenée C Niessen, Jan H Kleibeuker, Helga Westers, et al.
Clinical & Developmental Immunology|October 2, 2010
Potential target antigens for a universal vaccine in epithelial ovarian cancerRenee Vermeij, Toos Daemen, Geertruida H de Bock, et al.
Gynecologic Oncology|November 16, 2017
Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic reviewNienke C Te Grootenhuis, Anne-Floor W Pouwer, Geertruida H de Bock, et al.
Gynecologic Oncology|December 5, 2009
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancerEvelien W Duiker, Ate G J van der Zee, Pauline de Graeff, et al.
Pageof 14